510(k) K790712
K790712 is an FDA 510(k) premarket notification submitted by Kent Laboratories, Inc. for the device "ANTISERUM TO HUMAN, ALPHA-2-MACROGLOBULI". The FDA issued a decision of Substantially Equivalent on Aug 16, 1979. The device falls under product code DDB (Ceruloplasmin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5210. Kent Laboratories, Inc. has 39 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 16, 1979
- Date Received
- Apr 12, 1979
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Ceruloplasmin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5210
- Review Panel
- IM
- Submission Type
- 510(k) Exempt
Need the full FDA record for Kent Laboratories, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.